Cvr Partners, Lp
UAN NYSE Agricultural Chemicals Financials FY2016βFY2025
What Cvr Partners, Lp does
No business description yet.
- Legal name
- CVR PARTNERS, LP
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 18, 2026
- Accession Β· CIK
- 0001425292-26-000011
0001425292
Revenue and margins
Cvr Partners, Lp had $606M of revenue in fiscal 2025, up 15.4% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $98.8M in fiscal 2025, 16.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Cvr Partners, Lp returned β to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Cvr Partners, Lp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $113M | $86.3M | $45.3M | $90.9M | $69.2M |
| Debt incl. finance leases | $611M | $547M | $547M | $590M | $591M |
| Net debt / EBITDA | 2.4x | 1.1x | 1.8x | 2.8x | 2.5x |
| Current ratio | 1.6x | 2.1x | 2.2x | 2.1x | 2.2x |
| Quick ratio | 1.3x | 1.5x | 1.3x | 1.4x | 1.4x |
| Total assets | $1.1B | $1.1B | $975M | $1.0B | $969M |
| Net debt (β = net cash) | $498M | $460M | $502M | $499M | $522M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 2 / 9 | 7 / 9 | 7 / 9 | 3 / 9 | 9 / 9 | 9 / 9 | 5 / 9 | 5 / 9 | 8 / 9 |
| Accruals ratio | β5.5% | β6.5% | β6.6% | β6.2% | β10.9% | β10.2% | β1.3% | β6.8% | β9.0% | β5.1% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $356M | $331M | $351M | $404M | $350M | $533M | $836M | $681M | $525M | $606M |
| Net interest income | β$48.6M | β$62.8M | β$62.6M | β$62.6M | β$63.4M | β$61.0M | β$34.1M | β$28.7M | β | β |
| Gross profit | $54.1M | $15.6M | $31.7M | $56.6M | $24.8M | $162M | $352M | $232M | $119M | $163M |
| Operating income | $24.6M | β$10.3M | $6.3M | $27.4M | β$34.9M | $134M | $320M | $201M | $90.4M | $129M |
| Interest expense | $48.6M | $62.9M | β | β | β | β | β | β | β | β |
| Pretax income | β$26.6M | β$72.6M | β$50.1M | β$35.0M | β$98.2M | $78.2M | $287M | $173M | $61.0M | $98.6M |
| Income tax | $0.3M | $0.2M | β$0.0M | β$0.0M | $0.0M | $0.1M | $0.2M | $0.3M | $0.1M | β$0.0M |
| Net income | β$26.9M | β$72.8M | β$50.0M | β$35.0M | β$98.2M | $78.2M | $287M | $172M | $60.9M | $98.7M |
| Diluted EPS | β$0.26 | β$0.64 | β$4.42 | β$3.09 | β$8.77 | $7.31 | $27.07 | $16.31 | $5.76 | $9.33 |
| Diluted shares | 0.10B | 0.11B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $45.0M | $10.4M | $32.2M | $39.2M | $19.7M | $189M | $301M | $244M | $151M | $150M |
| Capital expenditure | $23.2M | $14.6M | $19.8M | $18.7M | $18.6M | $20.6M | $44.7M | $24.2M | $37.1M | $50.8M |
| Free cash flow | $21.7M | β$4.2M | $12.4M | $20.5M | $1.1M | $168M | $257M | $219M | $113M | $98.8M |
| Depreciation and amortization | $58.2M | $74.0M | $71.6M | $79.8M | $76.1M | $73.5M | $82.1M | $79.7M | $88.1M | $81.9M |
| Stock-based compensation | $2.8M | $3.0M | $3.0M | $3.4M | $1.0M | $23.1M | $25.3M | $8.2M | $4.9M | $9.8M |
| Acquisitions | $63.9M | $0.0M | $0.0M | β | β | β | β | β | β | β |
| Share buybacks | β | β | $0.0M | $0.0M | $7.1M | $0.5M | $12.4M | $0.0M | $0.0M | β |
| Dividends and buybacks | β | β | $0.0M | $0.0M | $7.1M | $0.5M | $12.4M | $0.0M | $0.0M | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $55.6M | $49.2M | $61.8M | $37.0M | $30.6M | $113M | $86.3M | $45.3M | $90.9M | $69.2M |
| Total debt | $623M | $626M | $629M | $632M | $636M | $611M | $547M | $547M | $569M | $570M |
| Finance lease liabilities | β | β | β | $0.2M | $0.1M | β | β | β | $21.0M | $21.4M |
| Current assets | $135M | $118M | $194M | $125M | $118M | $262M | $266M | $166M | $234M | $214M |
| Current liabilities | $63.0M | $56.1M | $123M | $75.5M | $76.3M | $162M | $126M | $75.5M | $111M | $96.8M |
| Inventory | $58.2M | $53.2M | $63.6M | $48.3M | $42.3M | $52.3M | $77.5M | $69.2M | $75.6M | $82.7M |
| Property and equipment, net | $1.1B | $1.1B | $1.0B | $952M | $898M | $850M | $811M | $761M | β | β |
| Goodwill | $41.0M | $41.0M | $41.0M | $41.0M | $0.0M | $0.0M | $0.0M | β | β | β |
| Total assets | $1.3B | $1.2B | $1.3B | $1.1B | $1.0B | $1.1B | $1.1B | $975M | $1.0B | $969M |
| Margins | ||||||||||
| Gross margin | 15.2% | 4.7% | 9.0% | 14.0% | 7.1% | 30.4% | 42.2% | 34.1% | 22.6% | 27.0% |
| Operating margin | 6.9% | β3.1% | 1.8% | 6.8% | β10.0% | 25.3% | 38.3% | 29.6% | 17.2% | 21.2% |
| EBITDA margin | 23.2% | 19.3% | 22.2% | 26.5% | 11.8% | 39.0% | 48.1% | 41.3% | 34.0% | 34.7% |
| Net margin | β7.6% | β22.0% | β14.2% | β8.7% | β28.1% | 14.7% | 34.3% | 25.3% | 11.6% | 16.3% |
| FCF margin | 6.1% | β1.3% | 3.5% | 5.1% | 0.3% | 31.6% | 30.7% | 32.2% | 21.6% | 16.3% |
| Net interest share of revenue | β13.6% | β19.0% | β17.8% | β15.5% | β18.1% | β11.4% | β4.1% | β4.2% | β | β |
| Returns | ||||||||||
| Return on capital employed | 2.0% | β0.9% | 0.6% | 2.6% | β3.6% | 13.9% | 32.8% | 22.4% | 10.0% | 14.7% |
| Return on assets | β2.1% | β5.7% | β4.0% | β2.9% | β9.0% | 7.2% | 25.8% | 16.6% | 6.1% | 9.9% |
| Growth | ||||||||||
| Revenue growth | β | β7.2% | 6.1% | 15.1% | β13.4% | 52.2% | 56.9% | β18.4% | β22.9% | 15.4% |
| Net income growth | β | β | β | β | β | β | 267.0% | β39.9% | β64.7% | 62.0% |
| EPS growth | β | β | β | β | β | β | 270.3% | β39.7% | β64.7% | 62.0% |
| FCF growth | β | β119.1% | β | 65.0% | β94.4% | 14,622.5% | 52.7% | β14.6% | β48.3% | β12.9% |
| Share count change | β | 9.7% | β90.0% | 0.0% | β1.2% | β4.6% | β0.9% | β0.2% | 0.0% | 0.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | 6.9x | 9.1x | 7.3x | 5.6x | 14.7x | 2.4x | 1.1x | 1.8x | 2.8x | 2.5x |
| Interest coverage | 0.5x | β0.2x | β | β | β | β | β | β | β | β |
| Current ratio | 2.1x | 2.1x | 1.6x | 1.7x | 1.5x | 1.6x | 2.1x | 2.2x | 2.1x | 2.2x |
| Quick ratio | 1.2x | 1.2x | 1.1x | 1.0x | 1.0x | 1.3x | 1.5x | 1.3x | 1.4x | 1.4x |
| Capital allocation | ||||||||||
| Capex / revenue | 6.5% | 4.4% | 5.6% | 4.6% | 5.3% | 3.9% | 5.3% | 3.6% | 7.1% | 8.4% |
| Stock comp / revenue | 0.8% | 0.9% | 0.9% | 0.9% | 0.3% | 4.3% | 3.0% | 1.2% | 0.9% | 1.6% |
| Payouts / FCF | β | β | 0.0% | 0.0% | 619.6% | 0.3% | 4.8% | 0.0% | 0.0% | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 2.0 | 7.0 | 7.0 | 3.0 | 9.0 | 9.0 | 5.0 | 5.0 | 8.0 |
| Accruals ratio | β5.5% | β6.5% | β6.6% | β6.2% | β10.9% | β10.2% | β1.3% | β6.8% | β9.0% | β5.1% |
Source: SEC EDGAR XBRL filings (CIK 0001425292). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.